ADP-lnduced Platelet Activation

References

• Devary A. N., Szent-Gyorgi A. The physiological activity of adenine compounds, with special reference to their action on heart. J. Physiol. 1929; 68: 213–217
   Google Scholar
• Su C. Purinergic neurotransmission and neuromodulation. Ann. Rev. Pharmacol. Toxicol. 1988; 23: 397–411
   Google Scholar
• Green H., Stoner H. B. Biological Actions of Nucleotides. H. K. Lewis & Co., Ltd., London 1950
   Google Scholar
• Burnstock G., Kennedy C. A dual function of adenosine 5′-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally realesed intravascular agents. Circ. Res. 1986; 58: 319–330
   PubMed Web of Science ®Google Scholar
• Olson R. A., Pearson J. D. Cardiovascular purinoreceptors. Physiol. Rev. 1990; 70: 761–849
   Google Scholar
• Dubyak G. R. Signal transduction by P2-purinergic receptors for extracellular ATP. Am. J. Respir. Cell Mol. Biol. 1991; 4: 295–300
   PubMed Web of Science ®Google Scholar
• Von Kugelgen I., Strake K. Noradrenaline-ATP cotransmission in symphathetic nervous system. Trends Pharmacol. Sci. 1991; 12: 319–324
   PubMed Web of Science ®Google Scholar
• Bean B. P. Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol. Sci. 1990; 13: 87–91
   Google Scholar
• Burnstock G. Purinergic mechanisms. Ann. N.Y. Acad. Sci. 1990; 603: 1–17
   PubMed Web of Science ®Google Scholar
• El-Moatassim C., Dornand J., Mani J. C. Extracellular ATP and cell signalling. Biochim. Biophy. Acta 1992; 1134: 31–45.
   PubMedGoogle Scholar
• Vassort G., Scamps F., Puceat M L, Clement O. Multiple effects of extracellular ATP in cardiac tissues. News Physiol. Sci. 1992; 7: 212–215
   Google Scholar
• Dubyak G. R., El-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 1993; 265: C577–C606
   PubMed Web of Science ®Google Scholar
• Apasov S., Koshiba M., Redgeld F., Sitrovsky M. V. Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytoxic T-lymphocyte effector functions. Immunol. Rev. 1995; 146: 5–19
   PubMed Web of Science ®Google Scholar
• Baricordi R., Ferrair D., Mechiorri L., Chiozzi P., Hanan S., Chiari E., Rubin M., Di Virgilio F. An ATP-channel is involved in mitogenic stimulation of human T-lymphocyte. Blood 1996; 86: 682–690
   Google Scholar
• Zheng L., Zychlinski A., Liu C., Ojcius D., Young J. Extracellular ATP as a trigger for apoptosis or programmed cell death. J. Cell Biol 1991; 112: 279–285.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F. The purinergic P2Z receptor. An intriguing role in immunity, inflamation and cell death. Immunol. Today 1995; 16: 524–528
   PubMedGoogle Scholar
• Hellem A. J. The adhesiveness of human blood platelets in vitro. Scand. J. Clin. Lab. Invest. 1960; 12: 1–117
   PubMed Web of Science ®Google Scholar
• Olligard E. Macroscopic studies of platelet aggregation: nature of an aggregating factor in red blood cells and platelets. Thromb. Diath. Haemorrh. 1961; 6: 86–97
   Google Scholar
• Gaarder A., Jonsen A., Laland S., Hellem A. J., Owem P. Adenosine diphosphate in red cells as a factor of human blood platelets. Nature 1961; 192: 531–532
   PubMed Web of Science ®Google Scholar
• Born G. V. R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929
   PubMed Web of Science ®Google Scholar
• Clayton S., Cross M. J. The aggregation of platelets by catecholamine and by thrombin. J. Physiol. 1963; 169: 82P–83P
   Web of Science ®Google Scholar
• Clayton S., Born G. V. R., Cross M. J. Inhibition of the aggregation of blood platelets by nucleosides. Nature 1963; 200: 138–139
   PubMed Web of Science ®Google Scholar
• Haslam R. J. Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and fatty acids. Nature 1964; 202: 765–68
   PubMed Web of Science ®Google Scholar
• Haslam R. J. Mechanisms of blood platelet aggregation. Physiology of Hemostasis and Thrombosis, S. A. Johnson, W. H. Seegers. Charles C. Thomas, Springfield, IL 1967; 88–112
   Google Scholar
• Willerson J. T., Campbell W. B., Winniford H. D., Schmitz J., Apprill P., Firth B. G., Ashton J., Smitherman T., Bush L., Buja L. M. Conversion from chronic to acute coronary artery disease: speculations regarding mechanisms. Am. J. Cardiol. 1984; 54: 1349–1354
   PubMed Web of Science ®Google Scholar
• Willerson J. T., Hills L. D., Winniford M., Buja L. M. Speculations regarding mechanisms responsible for acute ischemic heart disease syndromes. J. Am. Coll. Cardiol. 1986; 8: 245–250
   PubMed Web of Science ®Google Scholar
• Willerson J. T., Golino P., Eidt J., Campbell W. B., Buja L. M. Specific platelet mediators and unstable coronary artry lesions: Experimental evidence and potential clinical implications. Circulation 1989; 80: 198–205
   PubMed Web of Science ®Google Scholar
• Davis M. J., Thomas A. C. Plaque fssuring: the cause of acute myocardial infarction, sudden death, and crescendo angina. Br. Heart J. 1985; 53: 363–373
   Google Scholar
• Fuster V., Bradmon L., Cohen M., Ambrose J. A., Bradmon J. J., Chesboro J. H. Insights into pathogenisis of acute ischemic syndromes. Circulation 1988; 77: 1213–1220
   PubMed Web of Science ®Google Scholar
• Davis M. J. Mechanisms of thrombosis and atherosclerosis. Haemostasis and Thrombosis: Basic Principles and Clinical Practice, R. W. Colman, J. Hirsh, V. J. Marder, E. W. Salzman. J. B. Lippincott Company, Philadelphia 1994; 1224–1237
   Google Scholar
• Baumgartner H. R. The role of blood flow in platelet adhesion and, fibrin formation of murual thrombi. Microvasc. Res. 1973; 5: 167–179
   PubMed Web of Science ®Google Scholar
• Baumgartner H. R., Muggli R., Tschopp T. B., Turitto V. T. Platelet adhesion, release and aggregation in flowing blood: effect of surface properties and platelet function. Thromb. Haemost. 1976; 35: 124–138
   PubMed Web of Science ®Google Scholar
• Turittio V. T., Weiss H. J., Zimmerman T. S., Susman I. L. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823–831
   Google Scholar
• Stel H. V., Sakariassan K. S., De Groot P. G., van Maurik J. A., Sixma J. J. von Willebrand factor in the vessal wall mediates platelet adhesion. Blood 1985; 6: 329–357
   Google Scholar
• Kieffer N., Phillips D. R. Platelet membrane glycoproteins: functions in cellular interactions. Ann. Rev. Cell Biol. 1990; 6: 329–357
   PubMedGoogle Scholar
• Nurden A. T., Nurden P. A review of the role of platelet membrane glycoproteins in the platelet vessel wall interaction. Balliere's Clinical Hematology 1993; 6: 653–690
   PubMedGoogle Scholar
• Zawilska K. M., Born G. V. R., Bengent N. A. Effect of ADP-utilizing enzymes on arterial bleeding time in rats and rabbits. Br. J. Haematol. 1982; 50: 317–325
   Google Scholar
• Schror K. The basic pharmacology of ticlopidine and clopidogrel. Platelets 1993; 4: 252–261
   PubMed Web of Science ®Google Scholar
• Yao S.-K., Ober J. C., McNatt J., Benedict C. R., Rosolowski M., Anderson H. V., Cui K., Maffrand J.-P., Campbell W. B., Buja L. M., Willerson J. T. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circulation Res. 1991; 70: 39–48
   Google Scholar
• Panak E., Maffrand J. P., Picard-Fraire C., Valles E., Blanchard J., Rencucci R. Ticlopidine: a promise for prevention and treatment of thrombus and its complications. Haemostasis 1983; 13: 1–54., Suppl 1
   PubMedGoogle Scholar
• Mc Thenault J., Ewen J., McCrew A., Bouloux C., Jacob C., Chigot C., Irvine A., Kindermans M., Maffrand J. P., Rencucci R. PCR 4099. A new antithrombotic drug, evaluation of tolerence and pharmacological activity. Thromb. Res 1986; 286, Suppl 6
   Google Scholar
• Maffrand J. P., Bernat A., Delebassee D., Defreyn G., Cazenave J. P., Gorden J. L. ADP plays a key role in thrombogenesis in rats. Thromb. Haemost. 1988; 59: 225–230
   PubMed Web of Science ®Google Scholar
• Cattaneo M., Leochi A., Randi A. M. N., McGregor J. L., Mannucci P. M. Identification of new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787–2796
   PubMed Web of Science ®Google Scholar
• Nurden P., Savi P., Heilman E., Bihour C., Herbert J-M., Maffrand J.-P., Nurden A. T. An inherited bleeding disorder linked to defective interaction between ADP and its receptor on platelets. J. Clin. Invest. 1995; 95: 1612–1622
   PubMed Web of Science ®Google Scholar
• George J. N., Nurden A. T., Phillips D. R. Molecular defects in inter-tactions of platelets with the vessel wall. N. Engl. J. Med. 1984; 311: 1084–1098
   PubMed Web of Science ®Google Scholar
• Weiss H. J. Inherited abnormalities of platelet granules and signal transduction. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, R. W. Colman, J. Hirsh, V. J. Marder, E. W. Salzman. J. B. Lippincott Company, Philadelphia 1994; 1224–1237
   Google Scholar
• Kim B. K., Zamecenik P., Taylor G., Guo M. J., Blackburn M. Antithrombotic effect of β,β′-monochloromethylenediadenosine5′,5′-P1,P4-tetraphosphate. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 11056–11058
   PubMed Web of Science ®Google Scholar
• Vilen L., Jacobsson S., Kutti J. ADP-induced platelet aggregation as a function of age in healthy humans. Thromb. Hemost. 1989; 61: 490–492
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic nerves. Pharmacol. Rev. 1972; 24: 509–581
   PubMed Web of Science ®Google Scholar
• Kenakin T. P., Bond R. A., Bonner T. I. Definition of pharmacological Receptors. Pharmacol. Rev. 1992; 44: 351–361
   PubMed Web of Science ®Google Scholar
• Burnstock G. A basis for distinguishing two types of purinergic receptors. Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, R. W. Sraub, L. Bolis. Raven Press, New York 1978; 107–118
   Google Scholar
• Van Calker P., Muller M., Hamprecht B. Adenosine regulates via two different types of receptors; the accumulation of cyclic AMP in cultured brain cells. J. Neurosci. 1979; 23: 999–1005
   Google Scholar
• Londos C., Cooper D. M. F., Wolff J. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 2551–2554
   PubMed Web of Science ®Google Scholar
• Kennedy C., Burnstock G. Evidence for an inhibtory prejunctional P1-purino receptor in rat portal vein with characteristics of A2-- rather than A1-subtype. Eur. J. Pharmac. 1984; 100: 363–368
   Google Scholar
• Linden J. Structure and function of A1 adenosine receptors. FASEB J. 1991; 5: 2668–2776
   PubMed Web of Science ®Google Scholar
• Barnard E. A., Burnstock G., Webb T. E. G-protein coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 1994; 15: 67–70
   PubMed Web of Science ®Google Scholar
• Burnstock G., Kennedy C. Is there a basis for distinguishing purinergic receptors. Gen. Pharmac. 1985; 16: 433–440.
   PubMedGoogle Scholar
• Cusack N. J., Hourani S. M. O. Subtypes of P2-Purinoreceptors: Studies using analogs of ATP. Ann. N. Y. Acad. Sci. 1990; 603: 172–181
   PubMed Web of Science ®Google Scholar
• Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem. J. 1986; 233: 309–319
   PubMed Web of Science ®Google Scholar
• Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P., Williams M. VI. Nomenclature and classification of purinoreceptors. Pharmacol. Rev. 1994; 46: 143–156
   PubMed Web of Science ®Google Scholar
• Pintor J., Miras-Portugal M. T. P2 purinergic, receptors for diadenosinepolyphosphates in the nervous system. Gen. Pharmacol. 1995; 26: 229–235
   Google Scholar
• Benham C. D., Tsien R. W. A novel receptor operates Ca2+ permeable channel activated by ATP in the smooth muscle. Nature 1987; 328: 275–278
   PubMed Web of Science ®Google Scholar
• Surprenant A., Buell G., North R. A. P2X receptors bring new structure to ligand-gated ion channels. Trends Neur. Sci. 1995; 18: 224–228
   PubMed Web of Science ®Google Scholar
• Brake A. G., Wagenbach M. J., Julius D. New structural motif for ligandgated ion channels defined by ionotropic ATP receptor. Nature 1994; 371: 519–523
   PubMed Web of Science ®Google Scholar
• Lambrecht G., Friebbe T., Grimm U., Windsceif U., Bungart E., Hildebrandt C., Beaumert H. G., Spatz-kümbel G., Mutschler E. PPADS, a novel functionally selective antagonist of P2 purinoreceptor mediated responses. Eur. J. Pharmacol. 1992; 217: 217–219
   PubMedGoogle Scholar
• Buell G., Michel A. D., Lewis C., Collo G., Humphrey P. P. A., Surprenant A. P2X1 receptor activation in HL60 cells. Blood 1996; 87: 2659–2664
   PubMed Web of Science ®Google Scholar
• Valera S., Hussey N., Evans R. J., Adami N., Norte R. A., Surprenant A., Buell G. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 1994; 371: 516–519
   PubMed Web of Science ®Google Scholar
• O'Connor S. E., Dainty I. A., Leff P. Further subclassification of ATP Receptors based on agonist studies. Trends Pharmacol. Sci. 1991; 12: 137–141
   PubMed Web of Science ®Google Scholar
• Yammada M., Hamamori Y., Akita H., Yokoyama M. P2-purinoreceptor activation stimulates phosphoinositide hydrolysis and inhibits accumulation of cAMP in cultured ventricular monocytes. Circulation Res 1992; 70: 477–85
   Google Scholar
• Boyer J. L., Lazarowski I. R., Cheu X.-H., Harden T. K. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase. J. Pharmacol. Exp. Ther. 1993; 267: 1140–1146
   Google Scholar
• Bruner G., Murphy S. ATP-evoked arachidonic acid mobilization in astrocytes is via a P2Y-Purinergic receptor. J. Neurochem. 1990; 55: 1569–1575
   Google Scholar
• Hoyl C. H., Knight G. C., Burnstock G. Suramin antagonizes responses to P2-purinoreceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and E. coli. Br. J. Pharmacol. 1990; 99: 617–621.
   Google Scholar
• Ayanathan K., Webb T. E., Sandhu A. K., Athwal R. S., Barnard G. A., Kunapuli S. P. Cloning and chromosomal localization of the human P2Y1 receptor. Biochem. Biophys. Res. Commun. 1996; 218: 783–788
   Google Scholar
• Parr C. E., Sullivan D. M., Paradiso A. M., Lazarowski G. R., Burch L. H., Olsen J. C., Erb L., Weimann G. A., Boucher R. C., Turner J. T. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 3275–3279
   PubMed Web of Science ®Google Scholar
• Akabar G. K. M., Dessari V. P., Sheth S., Mills D. C. B., Kunapuli S. P. Identification of two calcium signalling P2T and P2U purinergic receptors in human erythroleukemia cells. FASEB J 1995; 9: 684, (Abstract)
   Google Scholar
• Niguyen T., Erb L., Weisman G. A., Murschese A., Heng H. H. Q., Gurrard R. C., George S. P., Turner J. T., O'Dowd B. F. Cloning and expression, and chromosomal localiztion of the human uridine receptor gene. J. Biol. Chem. 1995; 270: 30846–30848
   Google Scholar
• Communi D., Priotton S., Parmentier M., Boeynaems J. M. Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem. 1995; 270: 30849–30852
   PubMed Web of Science ®Google Scholar
• Webb T. E., Kaplan M. H., Barnard E. A. Identification of 6H1 as a P2Y purinoreceptor: P2Y5. Biochem. Biophys. Res. Commun. 1996; 219: 105–110
   PubMedGoogle Scholar
• Chang K., Hanaoka K., Kumada M., Takuwa Y. Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J. Biol. Chem. 1995; 270: 26152–26158
   PubMed Web of Science ®Google Scholar
• Akbar G. K. M., Dasari V. R., Webb T. E., Ayanathan K. P., Pillarisetti K., Sandhu A. K., Athwal R. S., Daniel J. L., Ashby B., Barnard E. A., Kunapuli S. P. Molecular cloning of a novel P2 purinoreceptor from human erythroleukemia cells. J. Biol. Chem. 1996; 271: 18363–18367
   PubMedGoogle Scholar
• Hilbert M. F., Trumpp-Kallmeyer S., Hoflock J., Bruinvels A. This is not a G-protein-coupled receptor. Trends Pharmacol. Sci. 1993; 14: 7–12
   Google Scholar
• Cockroft S., Gomperts B. D. Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to mast cells. J. Physiol. 1979; 296: 229–243
   PubMed Web of Science ®Google Scholar
• Tatham P. E. E., Cusack N. J., Gomperts B. D. Chracterization of the ATP4-receptor that mediates permeabilization of rat mast cells. Eur. J. Pharmacol. 1988; 147: 13–21
   PubMed Web of Science ®Google Scholar
• Erb L., Lustig K. D., Sullivan D. M., Turner J. T., Weisman G. A. Functional expression and photoaffinity labeling of a cloned P2U Purinergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 5113–5117
   Google Scholar
• Lustig K. D., Shian A. K., Brake A. J., Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 5113–5117
   PubMed Web of Science ®Google Scholar
• Clarke L. L., Grubb B. R., Yankaskas J. R., Cotton C. U., Mekenzie A., Boucher R. C. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level decreases in cftr(-/-) mice. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 479–483
   PubMed Web of Science ®Google Scholar
• Bear C. E., Li C., Kartner N., Bridges R. J., Jensen J. R., Ramjeesingh M., Riorden J. R. Purification and functional reconstitution of the cystic fibrosis transmission conductance regulator. Cell 1992; 68: 809–818
   PubMed Web of Science ®Google Scholar
• Mason S. J., Paradiso A. M., Boucher R. C. Regulation of trans epithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br. J. Pharmacol. 1991; 103: 1649–1656
   PubMed Web of Science ®Google Scholar
• Knowles M. R., Lane L., Clarke D. V. M., Boucher R. C. Activation of extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 1991; 325: 533–538
   PubMed Web of Science ®Google Scholar
• Cusack N. J., Hourani S. M. O. Adenosine-5′-diphosphate antagonists and human platelets: No evidence that aggregation and inhibition of adenylate cyclase are mediated by different Receptors. Br. J. Pharmacol. 1982; 76: 221–227
   PubMed Web of Science ®Google Scholar
• Macfarlane D. E., Mills D. C. B. The effects of ATP on platelets: evidence against centeral role of released ADP in primary aggregation. Blood 1975; 46: 309–320
   PubMed Web of Science ®Google Scholar
• Rink T. J., Hallam T. J. What turns platelets on. Trends Biochem. Sci. 1984; 9: 215–219.
   Web of Science ®Google Scholar
• Hallam T. J., Rink T. J. Response to adenosine diphosphate in human blood platelets loaded with the flourescent calcium indicator Quin-2. J. Physiol. 1985; 368: 131–146
   PubMed Web of Science ®Google Scholar
• Sage S. O., Reast R., Rink T. J. ADP evokes biphasic Ca2+ influx in Fura-2 loaded human platelets. Evidence for Ca2+ entry regulated by the intracellular store. Biochem. J. 1990; 265: 675–680
   PubMed Web of Science ®Google Scholar
• Sage S. O., Rink T. Kinetic differences between thrombin- and ADP-induced calcium influx and release from internal stores in fura-2 loaded human platelets. Biochem. Biophys, Res. Commun. 1986; 136: 1124–1129
   PubMed Web of Science ®Google Scholar
• Mahaut-Smith M. P., Sage S. O., Rink T. J. Rapid ADP-evoked currents in human platelets recorded with nystatin permeabilized patch technique. J. Biol. Chem. 1990; 267: 3060–3065
   Google Scholar
• Macfarlane D. E., Mills D. C. B. Inhibition by ADP of prostaglandin-induced accumulation of cyclic AMP in human platelets. J. Cyclic Nucleotide Res. 1981; 7: 1–11
   Google Scholar
• Cusack N. J., Hourani S. M. O. Competitive inhibition by adenosine 5′-triphosphate of the actions of human platelets by 2-chloroadenosine 5′-diphosphate, 2-azidoadenosine 5′-diphosphate and 2-methylthioadenosine 5′-diphosphate. Br. J. Pharmacol. 1982; 11: 329–333
   Google Scholar
• Macfarlane D. E., Srivastva P. C., Mills D. C. B. 2-methylthioadenosine [β-32P]diphosphate: an agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in platelets. J. Clin. Invest. 1983; 71: 420–428
   PubMed Web of Science ®Google Scholar
• Fugman D. A., Write D. P., Jones L. A. C., Aronow B. J., Liberman M. A. In vitro establishment and characterization of a human megakaryoblastic cell line. Blood 1990; 75: 1252–1261
   PubMed Web of Science ®Google Scholar
• Kalambakas S. A., Robertson F. M., O'Connell S. M., Sinha S., Vishnupad K., Karp G. I. Adenosine diphosphate stimulation of cultured hematopoietic cell lines. Blood 1993; 81: 2652–2657
   PubMedGoogle Scholar
• Shi X.-P., Yin K.-C., Gardell S. J. Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor. Thromb. Res. 1995; 77: 235–247
   PubMed Web of Science ®Google Scholar
• Murgo A. J., Contrera J. G., Sistare F. D. Evidence for seperate calciumsignalling P2T and P2U purinoreceptors in human megakaryoblasic Dami Cells. Blood 1994; 83: 1258–1267
   PubMed Web of Science ®Google Scholar
• Floddgard H., Klenow H. Abundent amount of diadenosine diadenosine 5′,5′-P1,P4-tetraphosphate are present and releasable but metabollically inactive in human platelets. Biochem. J. 1982; 208: 737–742
   Google Scholar
• Luthje J., Ogilvie A. The presence of diadenosine 5′,5-P1,P3-triphos-phate (Ap3A) in human platelets. Biochem. Biophys. Res. Commun. 1983; 115: 253–260
   PubMedGoogle Scholar
• Rodriguez Del Castillo A., Torres M., Dellicido E. G., Miras-Portugal M. T. Subcellular distribution studies of diadenosine polyphophates- Ap4A and Ap5A-in bovine adrenal medulla: presence in chrimaffin granules. J. Neurochem. 1988; 51: 1696–1703
   Google Scholar
• Luthje J., Barringer K., Ogilvie A. Effects of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) on platelet aggregation in unfractionated human blood. Blut 1985; 51: 405–413
   Google Scholar
• Harrison M. J., Brossmer R., Goody R. S. Inhibition of platelet aggregation and platelet release reaction by α,ω-diadenosine polyphosphates. FEBS Lett. 1975; 54: 57–60
   Google Scholar
• Mayo K. H., Mvele O. M., Pun R. N. Proton magnetic resonance spectroscopic analysis of diadenosine 5,5′-polyphosphates. FEBS Lett. 1990; 265: 97–100
   Google Scholar
• Castro E., Torres M., Miras-Portugal M. T., Gonzalez M. P. Effect of diadenosine polyphosphates on catecholamine secretion from isolated chromaffin cells. Br. J. Phatrmacol. 1990; 100: 360–364
   Google Scholar
• Jefferson J. R., Harmon J. T., Jamieson G. A. Identification of high affinity (Kd 0.35 μmol/L) and low affinity (Kd 7.9 μmol/L) platelet binding sites for ADP and competition by ADP analogs. Blood 1988; 71: 100–116
   Google Scholar
• Puri R. N., Kumar A., Chen H., Colman R. F., Colman R. W. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP-receptor, by 8-(4-bromo-2,3-dioxobutylthio)-ADP. J. Biol. Chem. 1995; 270: 24482–24488
   Google Scholar
• Gough G., Maguire M. H., Penglis F. Analogs of adenosine 5′-diphosphate: new platelet aggregators. Influence of purine ring and phosphate chain substituents on aggregatory of adenosine 5′-diphosphate. Mol. Pharmacol. 1972; 8: 170–177
   PubMed Web of Science ®Google Scholar
• Puri R. N., Colman R. F., Colman R. W. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5′-diphosphate is mediated by its binding to a putative ADP-receptor, aggregin. Eur. J. Biochem. 1996; 236: 862–870
   Google Scholar
• Colman R. W., Figures W. R., Scearce M. L., Strimpler A. M., Zhou F., Rao K. Inhibition of collagen induced platelet activation by 5′-fluorosulfonylbenzoyladenosine. Evidence for an ADP requirement and synergistic influence of prostaglandin endoperoxides. Blood 1986; 68: 565–570
   Google Scholar
• Pierce P. H., Wright J. M., Egan G., Scrutton M. C. Interaction of human platelets with 2,3-dialdehyde and 2,3-dialcohol derivatives of adenosine diphos-phate and adenosine triphosphate. Eur. J. Biochem. 1978; 88: 543–554
   Google Scholar
• Puri R. N., Colman R. W. Structural features in the ribose moiety of ADP necessary for interaction with aggregin, an ADP-receptor, during ADP-induced platelet responses: investigations using apolyclonal antibody. FASEB J 1997; 9: 329, (Abstract)
   Google Scholar
• Cusack N. J., Hourani S. M. O. Partial agonist behaviour of adenosine-5′-O-(2-thiodiphosphate). Br. J. Pharmacol. 1981; 73: 405–408
   PubMed Web of Science ®Google Scholar
• Cusack N. J., Hourani S. M. O. Effects of Rp and Sp diastereoisomers of adenosine-5′-O-(1-thiodiphosphate) on human platelets. Br. J. Pharmacol. 1981; 73: 409–412
   PubMed Web of Science ®Google Scholar
• Cusack N. J., Petty C. J. Effects of isopolar isosteric phosphonate analogues of adenosine 5′-diphosphate (ADP) on human platelets. Adenosine and Adenosine Nucleotides: Physiology and Pharmacology, D. M. Paton. Taylor and Francis, London 1988; 287
   Google Scholar
• Hourani S. M. O., Welford L. A., Cusack N. J. 2-MeS-AMP-PCP and human platelets: implications for the role of adenylate cyclase in ADP-induced aggregation. Br. J. Pharmacol. 1986; 87: 84P
   Google Scholar
• Cusack N. J., Hourani S. M. O. Specific and non-compatative inhibition by 2-alkylthio analogues of adenosine 5′-monophosphate and adenosine 5′-triphosphate of human platelet aggregation by adenosine 5′-diphosphate. Br. J. Pharmacol. 1982; 75: 397–400
   Google Scholar
• Cusak N. J., Hickmann M. E., Bom G. V. R. Effect of d- and l-enantiomers of adenine, AMP and ADP and their 2-chloro and 2-azido analogues on human platelets. Proc. R. Soc. London Ser B 1979; 206: 139–144
   Google Scholar
• Burnstock G., Cusack N. J., Hills J. M., Mackenzie A. I., Meghiji P. Studies on the stereoselectivity of P2-purinoreceptor. Br. J. Pharmacol. 1983; 79: 907–913
   PubMed Web of Science ®Google Scholar
• Cusack N. J., Born G. V. R. Effects of photolysable 2-azido analogues of AMP and ADP on human platelets. Proc. R. Soc. London SerB 1977; 197: 515–520
   PubMed Web of Science ®Google Scholar
• Cristalli G., Mills D. C. B. Identification of a receptor for ADP on blood platelets by photoaffinity labeling. Biochem. J. 1993; 291: 875–881
   PubMed Web of Science ®Google Scholar
• Jefferson J. R., Hunt J. B., Jamieson G. A. Facile synthesis of 2-[(3-aminopropyl)thio]adenosine 5′-diphosphate: a key intermediate for the synthesis of molecular probes of adenosine 5′-diphosphate function. J. Med. Chem. 1987; 30: 2013–2016
   PubMed Web of Science ®Google Scholar
• Puri R. N., Colman R. W. Modulation of platelet responses by 2-(3-bromo-2-oxopropylthio)adenosine 5′-diphosphate involves its binding to as well as covalent modification of an ADP-receptor, aggregin. Arch. Biochem. Biophys. 1997; 343: 140–145
   Google Scholar
• Cusack N. J., Born G. V. R. Inhibition of adenosine deaminase and of platelet aggregation by 2-azidoadenosine, a photolysable analogue of adenosine. Proc. R. Soc. London Ser. B 1976; 197: 307–311
   Google Scholar
• Macfarlane D. E., Mills D. C. B., Srivastva P. C. Binding of 2-azidoadenosine[β-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase. Biochemistry 1982; 21: 544–549
   Google Scholar
• Bennett J. E., Colman R. F., Colman R. W. Identification of adenine nucleotide proteins in human platelet membranes by affinity labeling by 5-p′-fluorosulfo-nylbenzoyladenosine. J. Biol. Chem. 1978; 253: 7346–7354
   PubMed Web of Science ®Google Scholar
• Colman R. F. Site specific modification of enzyme sites. Enzymes. Academic Press, New York 1990; 19: 283–321
   Google Scholar
• Agarwal A. K., Tandon N. N., Greco N. J., Jamieson G. A. Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced platelet aggregation. Thromb. Haemost. 1989; 62: 1103–1106
   Google Scholar
• Greco N. J., Yamamoto N., Jackson B. W., Tandon N. N., Moos M., Jr, Jamieson G. A. Identification of a nucleotide-binding site on glycoprotein IIb. J. Biol. Chem. 1991; 266: 13627–13636
   Google Scholar
• Powling M. J., Hardisty R. M. Glycoprotein IIb-IIIa complex and Ca2+ influx into stimulated platelets. Blood 1985; 66: 731–734
   PubMed Web of Science ®Google Scholar
• Greco N. J., Tandon N. N., Jackson B. W., Jamieson G. A. Low structural specificity for nucleoside triphosphates as antagonists of ADP-induced platelet activation. J. Biol. Chem. 1992; 267: 2966–2970
   Google Scholar
• Mayinger P., Gawaz M. Photoaffinity labeling of integrin αIIbβ3 (glycoprotein IIb-IIIa) on intact platelets with 8-azido-[γ-32P]ATP. Biochim. Biophys. Acta 1992; 1137: 77–81.
   Google Scholar
• Guthrow C. E., Allen J. E., Rasmussen H. Phosphorylation of an endogenous membrane associated cyclic adenosine 3′,5′-diphosphate dependent protein kinase in human erythrocyte ghosts. J. Biol. Chem. 1972; 247: 8145–8153
   PubMedGoogle Scholar
• Antonoff R. S., Ferguson J. J., Jr. Photoaffinity labeling with cyclic nucleotides. J. Biol. Chem. 1974; 249: 3319–3321
   Google Scholar
• Obrig T. G., Antonoff R. S., Kirwin K. S., Ferguson J. J., Jr. The binding of adenosine-3′,5′-monophosphate by messenger ribonucleotide-like particles. Biochem. Biophys. Res. Commun. 1975; 66: 437–443
   Google Scholar
• Schimmel P. R., Budzik G. P. Photo-cross-linking of protein-nucleic acid complexes. Methods Enzymol. 1977; 46: 168–180
   Google Scholar
• Photochemistry and Photobiology of Nucleotides, S. Y. Wang. Gordon & Beach, New York 1974
   Google Scholar
• Oswald R., Changeux J.-P. Ultraviolet light-induced labeling by non-competitive blockers of acetylcholine receptor from torpedo marmorata. Proc. Natl. Acad. Sci U.S.A. 1991; 78: 3925–3929
   Google Scholar
• Van Prooijen H. C., Van Marwizk-Kooy M., Van Weelden H., Aarts-Riemens M. I., Borghuis L., Akkerman J. W. N. Evidence of a new UVB source for irradiation of platelet concentrates. Br. J. Haemotol. 1990; 75: 573–577
   Google Scholar
• Van Marwizk-Kooy, Van Prooijen H. C., Van Asbeck B. S., Borghuis L., Akkerman J. W. N. Irradation of platelets with UV-B light exposes fibrinogen binding sites by an intracellualr mechanism. Br. J. Haematol. 1990; 75: 573–577
   Google Scholar
• Van Marwizk-Kooy M., Akkerman J. W.N., Van Asbeck B. S., Borghuis L., Van Prooijen H. C. UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Br. J. Haematol. 1990; 83: 253–258
   Google Scholar
• Grijzenhout M. A., Aarts-Riemens M. I., Akkerman J. W. N., Nienwenhuis H. K., Van Weelden H., Van Prooijen H. C. Ultraviolet-B irradiation of platelets induces a dose-dependent increase in the expression of platelet activation markers with storage. Br. J. Haematol. 1993; 83: 627–632
   Google Scholar
• Schieven G. L., Kirihara J. M., Gilliland L. K., Uckum F. M., Ledbetter J. A. Ultraviolet radiation rapidly induces tyrosine phosphorylation and calcium signalling in lymphocytes. Mol. Biol. Cell 1993; 4: 523–530
   Google Scholar
• Devary Y., Gottlieb R. A., Smeal T., Karin M. The ultraviolet response is triggered by activation of src tyrosine kinases. Cell 1992; 71: 1081–1091
   PubMed Web of Science ®Google Scholar
• Kyriakis J. M., Banerjee P., Nikolakaki E., Dai T., Rubie E. A., Ahmad M. F., Avruch J., Woodgett J. R. The stress activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156–160
   PubMed Web of Science ®Google Scholar
• Pombo C. M., Boventre J. V., Avruch J., Woodgett J. R., Kyriakis J. M., Force T. The stress activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J. Biol. Chem. 1994; 269: 26546–26551
   PubMed Web of Science ®Google Scholar
• Herrlich P. The mammalian genetic stress response. Adv. Enzyme Regul. 1984; 25: 485–504
   Google Scholar
• Roni Z. A., Lambert E., Weinstein J. B. Inducible cellular responses to ultraviolet light irradiation and other mediators of DNA damage in mammalian cells. Cell Biol. Toxicol. 1990; 6: 105–126
   Google Scholar
• Colman R. F. Protein Structure and Function: A Practical Approach, T. A. Creighton. IRL Press, New York 1989; 77–99
   Google Scholar
• Figures W. R., Niewiarowski S., Morinelli T. A., Colman R. F., Colman R. W. Affinity labeling of human platelet membrane protein with 5′-p-fluorosulfonylbenzoyladenosine. J. Biol. Chem. 1981; 256: 7789–7795
   Google Scholar
• Figures W. R., Scearce M. L., DeFeo P., Stewart G., Zhou F., Chen J., Daniel J. L., Colman R. F., Colman R. W. Direct evidence for the interaction of the nucleotide affinity analog 5′-p-fluorosulfonylbenzoyladenosine with a platelet ADP receptor. Blood 1987; 70: 796–803
   Google Scholar
• Colman R. W. Aggregin: a platelet ADP-receptor that mediates aggregation. FASEB J. 1990; 3: 1425–1435
   Google Scholar
• Colman R. W. Platelet ADP Receptors stimulating shape change and inhibiting adenylate cyclase. News Physiol. Sci. 1992; 7: 274–278
   Google Scholar
• Mills D. C. B., Figures W. R., Scearce M. L., Stewart G. J., Colman R. F., Colman R. W. Two mechanisms for inhibition of ADP-induced platelet shape change by 5′-p-fluorosulfonylbenzoyladenosine and covalent modification at an ADP binding site distinct from that inhibits adenylate cyclase. J. Biol. Chem. 1985; 260: 8078–8083
   Google Scholar
• Rao A. K., Kowalska M. A. ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5′-p-fluorosulfonylbenzoyladenosine is a weak platelet agonist. Blood 1987; 70: 751–756
   PubMed Web of Science ®Google Scholar
• Morinelli T. A., Niewiarowski S., Kornecki E., Figures W. R., Wachtfogel Y., Colman R. W. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogs. Blood 1983; 61: 41–49
   Google Scholar
• Figures W. F., Scearce M. L., Wachtfogel Y., Chen J., Colman R. F., Colman R. W. Platelet ADP receptor and α2-adrenoreceptor interaction: evidence of ADP-requirement for epinepherine-induced platelet activation and an influence of epinepherine on ADP-binding. J. Biol. Chem. 1986; 261: 5981–5986
   PubMed Web of Science ®Google Scholar
• Puri R. N., Zhou F., Bradford H., Hu C.-J., Colman R. F., Colman R. W. Thrombin-induced platelet aggregation involves an indirect cleavage of aggregin by calpain. Arch. Biochem. Biophys. 1989; 271: 346–358
   PubMed Web of Science ®Google Scholar
• Puri R. N., Zhou F., Colman R. F., Colman R. W. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain. Am. J. Physiol. 1990; 259: C862–C868
   Google Scholar
• Patthy L., Smith E. L. Identification of functional arginine residues in ribonuclease A and lysozyme. J. Biol. Chem. 1975; 250: 565–569
   Web of Science ®Google Scholar
• De Camp D. L., Lim S., Colman R. F. Reaction of pyruvate kinase with the new nucleotide affinity label 8-(4-bromo-2,3-dioxobutylthio)adenosine 5′-diphosphate and 5′-triphosphate. J. Biol. Chem. 1988; 27: 7651–7658
   Google Scholar
• Ozturk D. H., Safer D., Colman R. F. Affinity labeling of bovine liver glutamate dehydrogenase with 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5′-diphosphate and 5′-triphosphate. Biochemistry 1990; 29: 7112–7118
   Google Scholar
• Puri R. N., Colman R. W. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence of covalent modification of cysteine and lysine residues. Arch. Biochem. Biophys. 1991; 286: 419–427
   Google Scholar
• Huang Y.-C., Colman R. F. Aspartyl peptide labeled by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5′-diphosphate in the allosteric ADP site of pig heart NAD+-dependent isocitrate dehydrogenase. J. Biol. Chem. 1989; 264: 12208–122214
   Google Scholar
• Huang Y.-C., Colman R. F. Affinity labeleing of the allosteric ADP activation site of NAD-dependent isocitrate dehydrogenase by 6-(4-bromo-2,3-dioxobutylthio)adenosine 5′-diphosphate. J. Biol. Chem. 1984; 259: 12481–124888
   Google Scholar
• Bhatnagar D., Roskoski R., Jr, Rosendahl M. S., Leonard N. Adenosine cyclic 3′,5′-diphosphate dependent protein kinase: a new fluorescence displacement technique for characterizing the nucleotide binding site on the catalytic subunit. Biochemistry, 22: 6310–6317.
   Google Scholar
• Colman R. W., Figures W. R., Wu Q. X., Chung X. Y., Morenelli T. A., Tuszynski G. P., Colman R. F., Niewiarowski S. Distinction between glycoprotein Ufa and a 100 kDa protein (aggregin) mediating ADP-induced platelet activation. Arch. Biochem. Biophys. 1988; 262: 298–306
   Google Scholar
• Zablocki J. A., Katzenellenbogen J. A., Carlson K. E., Norman M. J., Katzenellenbogen B. S. Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrols derivatives. J. Med. Chem. 1987; 10: 829–838
   Google Scholar
• Wrzeszczynski K. O., Colman R. F. Activation of bovine liver glutamate dehydrogenase by covalent reaction of adenosine 5′-O-[S-(4-bromo-2,3-dioxobutyl)thiophosphate] with arginine-459 in an ADP-regulatory site. Biochemistry 1994; 33: 11544–11553
   Google Scholar
• Bacon C. R., Bender R. A., Colman R. F. The reaction of 4-iodoactami-dosalicylic acid with TPN-dependent isocitrate dehydrogenase from pig heart. J. Biol. Chem. 1981; 236: 6593–6599
   Google Scholar
• Puri R. N., Bhatnagar D., Roskoski R., Jr. Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: fluorescent affinity labeling of the catalytic subunit from bovine skeltal muscle with o-phthalaldehyde. Biochemistry 1985; 24: 6499–6508
   Google Scholar
• Puri R. N., Bhatnagar D., Glass D. B., Roskoski R., Jr. Inactivation of guanosine cyclic 3′,5′-monophosphate dependent protein kinase from bovine lung by o-phthalaldehyde. Biochemistry 1985; 24: 6508–6514
   PubMedGoogle Scholar
• Mac Intyre D. E., Grainge C. A., Drummond A. H., Gordon J. L. Effect of thiol reagents on platelet transport processes and responses to stimuli. Biochem. Pharmacol. 1977; 26: 319–323
   Google Scholar
• Sato T., Hashizumi T., Fuji T. N-ethylmaleimde inhibits Ca2+ influx induced by collagen or arachidonate in rabbit platelets. Biochim. Biophys. Acta 1987; 928: 266–271
   Google Scholar
• Subarao K., Kakkar V. V., Ganguli P. Binding of pyridoxal phosphate to human platelets: its effect on platelet function. Thromb. Res. 1978; 13: 1017–1029
   Google Scholar
• Ghosh P. B., Whitehouse M. W. 7-chloro-4-nitro-benzo-2-oxa-1,3-diazole: a new fluorogenic reagent for amino acids and other amines. Biochem. J. 1968; 108: 155–156
   PubMed Web of Science ®Google Scholar
• Hartle F. T., Roskoski R., Jr. Adenosine cyclic 3′,5′-monophosphate protein kinase from bivine brain: Inactivation of the catalytic subunit and holoenzyme by 7-chloro-4-nitro-2,1,3-benzoxadiazole. Biochemistry 1982; 21: 5175–5183.
   Google Scholar
• Marquardt D., Center M. S. Involvement of vascular adenosine triphosphate activity in multidrug resistance in HL-60 cells. J. Natl. Cancer Inst. 1991; 83: 1098–1102
   PubMedGoogle Scholar
• Puri R. N., Colman R. W. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitro-benz-2-oxa-1,3-diazole by covalent modification of aggregin, a putative ADP-receptor. J. Cell. Biochem. 1996; 61: 97–108
   Google Scholar
• Puri R. N., Colman R. W. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3′-suIfonate (Woodward′s Reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor. Anal. Biochem. 1996; 240: 251–260
   Google Scholar
• Lewis R. N., George R., McElhaney R. N. Structure-function investigation of the membranes (Na+-Mg2+)-ATPase from Acholeplasma laidlawii B: studies of reactive amino acid residues using group specific reagents. Arch. Biochem. Biophys. 1986; 247: 201–210
   Google Scholar
• Jennings M. L., Anderson M. P. Chemical modification and labeling of glutamate residues at the stilbenedisulfonate site of human red blood cell band 3 protein. J. Biol. Chem. 1987; 262: 11435–11445
   Google Scholar
• Johnson A. R., Dekker E. E. Woodward′s Reagent K inactivation of Escerichia coli l-thronine dehydrogenase: Increases absorbance at 340–350 nm is due the modification of cysteine and histidine residues, not aspartate or glutamate carboxyl groups. Protein Science 1996; 5: 382–390
   Google Scholar
• Anestario M., Jr, Harrison M. L., Gaehlen R. L. Immunochemical detection of adenine nucleotide binding proteins to 5′-p-fluorosulfonylbenzoyladenosine. Anal. Biochem. 1990; 190: 60–65
   Google Scholar
• Puri R. N., Colman R. W. Immunoaffinity method to identify aggregin, an ADP receptor in human blood platelets. Arch. Biochem. Biophys 1997; 347: 263–270.
   Google Scholar
• Adler J. R., Handin R. I. Solubilization and characterization of a platelet membrane ADP-binding protein. J. Biol. Chem. 1979; 254: 1866–1872
   Google Scholar
• Nachman R. L., Ferris B. Binding of adenosine diphosphate by isolated membranes from human platelets. J. Biol. Chem. 1974; 249: 704–710
   Google Scholar
• Gachet C., Cattaneo M., Ohlman P., Hechler B., Lecchi A., Chevalier J., Cassel D., Mannuchi P. M., Cazenave J.-P. Purinoreceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br. J. Haematol. 1995; 91: 434–444
   PubMed Web of Science ®Google Scholar
• Savi B., Laplace M. CI., Maffrand J. P., Herbert J. M. Binding of [3H]-2-methylthio-ADP to rat platelets-effect of clopidogrel and ticlopidine. J. Pharm. Exp. Therp. 1994; 269: 772–777
   PubMed Web of Science ®Google Scholar
• Savi P., Laplace M. CI., Herbert J. M. Evidence for the existance of two different ADP-binding sites on rat platelets. Thromb. Res. 1994; 76: 157–169
   PubMed Web of Science ®Google Scholar
• Mills D. C. B., Puri R. N., Hu C.-J., Minniti C., Grana G., Freedman M. D., Colman R. F., Coalman R. W. Clopidogrel inhibits binding of ADP analogues to the receptor mediating platelet adenylate cyclase. Arterio. Thromb. 1992; 12: 431–436
   Google Scholar
• Soslau G., Parker J. Modulation of platelet function by extracellular adenosine triphosphate. Blood 1989; 74: 984–993
   PubMed Web of Science ®Google Scholar
• Soslau G., Brosky I., Parker J. Occupancy of P2 purinoreceptors with unique properties modulates the function of human platelets. Biochim. Biophys. Acta 1993; 1177: 199–207.
   PubMedGoogle Scholar
• White J. G., Rao G. H. R., Gerrad J. M. Effects of ionophore A23187 on blood platelets. Am. J. Pathol. 1974; 77: 135–149
   PubMed Web of Science ®Google Scholar
• Berridge M. J., Irvine R. F. Inositol phosphates in cell signalling. Nature 1989; 341: 197–205
   PubMed Web of Science ®Google Scholar
• Fisher G. J., Bakshian S., Baldssare J. J. Activation of human platelets with ADP causes a rapid rise in cytosolic free calcium without hydrolysis of phos-phatidyl-4,5-bisphosphate. Biochem. Biophys. Res. Commun. 1985; 129: 958–964
   PubMed Web of Science ®Google Scholar
• Sweatt J. D., Blair I. A., Cragoe E. J., Limbird L. E. Inhibition of Na+/H+ exchange block epinephrine- and ADP-induced stimulation of human phospholipase C by blockade of arachidonic acid release at a prior step. J. Biol. Chem. 1986; 261: 8660–8666
   PubMedGoogle Scholar
• Vickers J. D., Kinlough-Rathbone R. L., Mustard J. F. The decrease in phosphatidyl-4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation. Biochem. J. 1986; 237: 327–332
   PubMed Web of Science ®Google Scholar
• Llyod J. V., Nishizawa E. E., Joist J. H., Mustard J. F. Effect of ADP-induced aggregation on 32PO4 incorporation into phophatidic acid and phosphoinositides of rabbit platelets. Br. J. Haematol. 1973; 24: 589–604
   Google Scholar
• Vickers J. D., Kinlough-Rathbone R. L., Mustard J. F. Change in phosphatidyl-4,5-bisphosphate 10 seconds after stimulation of washed platelets with ADP. Blood 1982; 60: 1247–1250
   PubMedGoogle Scholar
• Feliste R., Simon M. F., Chap H., Douste-Blazy L., Defreyn G., Maffrand J. P. Effect of PCR 4099 on ADP-induced calcium movements and phosphatidic acid in rat platelets. Biochem. Pharmacol. 1988; 37: 2559–2564
   Google Scholar
• Daniel J. L., Dangelmeyer C. A., Selak M., Smith J. B. ADP stimulates IP3 formation in human platelets. FEBS Lett. 1986; 206: 299–303
   PubMed Web of Science ®Google Scholar
• Vickers J. D., Kinlough-Rathbone R. L., Packham M. A., Mustard J. F. Inositol phospholipid metabolism in human blood platelets stimulated by ADP. Eur. J. Biochem. 1990; 193: 521–528
   PubMedGoogle Scholar
• Gear A. R. L., Raha S. Calcium signalling and phosphoinosidite metabolism in platelets: subsecond events revealed by quenched flow techniques. Mechanisms of Platelet Activation and Control, K. S. Authi. Plenum Press, New York 1993; 57–67
   Google Scholar
• Jones G. D., Gear A. R. L. Subsecond calcium dynamics in ADP- and thrombin-stimulated platelets: a continuous-flow approach using Indo-1. Blood 1988; 71: 1539–1543
   Google Scholar
• Kroll M. K., Heliums J. D., McIntyre L. V., Schafer A. I., Moake J. L. Platelets and shear stress. Blood 1996; 88: 1625–1541
   Google Scholar
• Eudo M. Calcium release from sarcoplasmic reticulum. Physiol. Rev. 1977; 57: 71–108
   Google Scholar
• Galione A., Lee H. C., Busa W. B. Ca2+-induced Ca2+ release from sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science 1991; 253: 1143–1146
   PubMed Web of Science ®Google Scholar
• Galione A. Ca2+-induced Ca2+ release and its modulation by cyclic ADP-ribose. Trends Pharmacol. Sci. 1992; 13: 304–306
   PubMedGoogle Scholar
• Berridge M. J. Cytoplasmic calcium oscillations. A two pool model. Cell Calcium 1991; 12: 63–72
   PubMed Web of Science ®Google Scholar
• Tsenoda Y., Matsuno K., Tashiso Y. Spatial distribution and temporal change of cytoplasmic calcium in human platelets. Biochem. Biophys. Res. Commun. 1988; 156: 1152–1159
   Google Scholar
• Heemskerk J. W. M., Hoyland J., Mason W. T., Sage S. O. Spiking in cytosolic calcium concentrations in single fibrinogen bound Fura 2 loaded platelet. Biochem. J. 1992; 283: 379–383
   Google Scholar
• Authi K. S. Ca2+ homeostasis and intracellular pools in human platelets. Mechanisms of Platelet Activation and Control, K. S. Authi. Plenum Press, New York 1993; 83–104
   Google Scholar
• Murphy C. T., Elmore M., Kellie S., Westwick J. The relationship between cytosolic Ca2+sn-1,2-diacylglycerol and inositol-1,4,5-triphosphate in platelet-activating factor stimulated rabbit platelets. Biochem. J. 1991; 278: 255–261
   Google Scholar
• Putney J. W., Jr. A model for receptor regulated calcium entry. Cell Calcium 1986; 7: 1–12
   PubMed Web of Science ®Google Scholar
• Putney J. W., Jr. Capacitative calcium entry revisited. Cell Calcium 1990; 11: 611–624
   PubMed Web of Science ®Google Scholar
• Authi K. S., Bokkala S., Patel Y., Kakkar V. V., Munkonge F. M. Ca2+ release from platelet intracellular stores by thapisgargin and 2,5-di-(t-butyl) 1,4-benzhydroquinone. Relationship to Ca2+ pools and relavence in platelet activation. Biochem. J. 1993; 294: 119–226
   Google Scholar
• Alonso M. T., Alvarez J., Montero M., Sanchez A., Garcia-Sancho J. Agonist-induced Ca2+ influx into human platelets is secondary to emptying the intracellular Ca2+ stores. Biochem. J. 1990; 280: 783–789
   Google Scholar
• Alvarez J., Montero M., Garcia Sancho J. Cytochrome P-450 may link intracellular Ca2+ stores with plasma membrane Ca2+ influx. Biochem. J. 1992; 274: 193–197
   Google Scholar
• Sargent P., Clarkson W. D., Sage S. O., Heemskerk J. W. M. Calcium influx evoked by Ca2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor regulated Ca2+ entry. Cell Calcium 1992; 13: 553–564
   Google Scholar
• Kuno M., Gardner P. Ion channels activated by inositol-1,4,5-triphosphate in plasma membrane of human T-lymphocytes. Nature 1989; 326: 301–304
   Google Scholar
• Irvine R. F. “Quantal” calcium release and the control of Ca2+ entry by inositol phosphates—a possible mechanism. FEBS Lett. 1990; 263: 5–9
   PubMed Web of Science ®Google Scholar
• Rengaswamy A., Feinberg H. Inositol-1,4,5-triphosphate induced Ca2+ release from platelet plasma membrane vesicles. Biochem. Biophys. Res. Commun. 1988; 150: 1021–1026
   Google Scholar
• Klan A. A., Steiner J. P., Snyder S. H. Plasma membrane inositol-1,4,5-triphosphate receptor of lymphocytes; Selective enrichment of sialic acid and unique binding specificity. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 2849–2853
   Google Scholar
• Fujimoto T., Nakada S., Miyawake A., Mikoshiba K., Ogawa K. Localization of inositol-1,4,5-triphosphate receptor-like protein plasmalemmal caveolae. J. Cell Biol. 1992; 119: 1507–1513
   PubMedGoogle Scholar
• Sage S. O., Merrit J. E., Hallam T. J., Rink T. J. Receptor mediated Ca2+ entry in Fura-2 loaded human platelets stimulated with ADP and thrombin. Duel wavelength studies with Mn2+. Biochem. J. 1989; 258: 923–926
   PubMed Web of Science ®Google Scholar
• Mahaut-Smith M. P., Sage S. O., Rink T. J. Receptor activated single channels in intact human platelets. J. Biol. Chem. 1990; 265: 10479–10483
   PubMed Web of Science ®Google Scholar
• Suldan Z., Brass L. F. Role of glycoprotein IIb.IIIa complex in plasma membrane Ca2+ transport: a comparison of results obtained with platelets and human erythroleukemia cells. Blood 1991; 78: 2887–2893
   Google Scholar
• Yamaguchi A., Yamamoto N., Kitagawa H., Tanoue K., Yamazaki H. Ca2+ influx mediated through the GPIIb/IIIa complex during platelet activation. FEBS Lett. 1987; 225: 228–232
   PubMed Web of Science ®Google Scholar
• Fujimoto T., Fujimura K., Kuramoto A. Electrophysiological evidence that glycoprotein IIb-IIIa complex is involved in calcium channel activation on human platlete plasma membrane. J. Biol. Chem. 1991; 266: 16370–16375
   Google Scholar
• Home W. C., Simons E. R. Effects of amiloride on the response of human platelets to bovine a-thrombin. Thromb. Res. 1978; 13: 599–603
   Google Scholar
• Connolly T. M., Limbird L. E. Removal of extra platelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombion. Proc. Natl. Acad. Sci. U.S.A. 1988; 80: 5320–5324
   Google Scholar
• Sweatt J. D., Johnson S. L., Cragoe J. E., Limbird L. E. Inhibitors of Na+/ H+ exchange block stimulus provoked arachidonic acid release in human platelets. J. Biol. Chem. 1985; 260: 12910–12919
   PubMed Web of Science ®Google Scholar
• Siffert W., Gengenbach S., Sheid P. Inhibition of platelet aggregation by amiloride. Thromb. Res. 1986; 44: 235–240
   Google Scholar
• Zavoico G. B., Cragoe E. J., Feinstein M. B. Regulation of intracellular pH in human platelets. J. Biol. Chem. 1986; 261: 13160–13167
   PubMed Web of Science ®Google Scholar
• Siffert W., Akkerman J. W. N. Na+/H+ exchange as a modulator of platelet activation. Trends Biochem. Sci. 1988; 13: 148–151
   PubMed Web of Science ®Google Scholar
• Feinberg H., Sandier W. C., Scorer M., Le Breton G. C., Grossman B., Born G. V. R. Movement of sodium into human platelets induced by ADP. Biochim. Biophys. Acta 1977; 470: 317–324
   PubMedGoogle Scholar
• Sweatt J. D., Connolly T. M., Cragoe E. J., Limbird L. E. Evidence that Na+/ H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets. J. Biol. Chem. 1986; 261: 8667–8673
   PubMedGoogle Scholar
• Apitz-Castro R. J., Mas M. A., Cruz M. R., Jain M. K. Isolation of homogeneous phospholipase A2 from human platelets. Biochem. Biophys. Res. Commun. 1979; 91: 63–71
   Google Scholar
• Jain M. K., Apitz-Castro R. Lag phase during the action of phospholipase A2 on phosphatidylcholine modified by alkanols. J. Biol. Chem. 1978; 253: 7005–7010
   Google Scholar
• Siffert W., Siffert G., Scheid P., Akkerman J. W. N. Na+/H+ exchange modulates Ca2+ mobilization in human platelets stimulated by ADP and the thromboxane mimetic U46619. J. Biol. Chem. 1990; 264: 719–725
   Google Scholar
• Sage S. O., Rink T. J., Mahout-Smith M. Resting and ADP-evoked changes in cytosolic free sodium concentration in human platelets loaded with indicator SBFI. J. Physoiol. 1991; 44: 559–573
   Google Scholar
• De Cristofaro R., Landolfi R., De Candia E., Castagnola M., Di Cera E., Wyman J. Allosteric equilibria in the binding of fibrinogen to platelets. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 8473–8476
   Google Scholar
• De Cera E., Gill S. J., Wyman J. Canonical formulation of linkage thermodynamics. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 5077–5081
   Google Scholar
• De Cristofaro R., Landolfi R., De Cera E., Di Candia E., Castagnola M., De Candia E., Bizzi B. Inhibition of fibrinogen binding to human platelets by blockage of Na+/H+ exchange. Biochem. Biophys. Res. Commun. 1989; 161: 1282–1232
   Google Scholar
• Ross R. The pathogenesis of atherosclerosis-An update. N. Engl. J. Med. 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Border W. A., Russiatiti L. R. Transforming growth factor-β in diseases. The dark side of tissue repair. J. Clin. Invest. 1992; 90: 1–7
   PubMed Web of Science ®Google Scholar
• Amento E. P., Ehsami N., Palmer H., Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 1991; 11: 1223–1230
   PubMed Web of Science ®Google Scholar
• Schwartz L., Bourassa M. G., Lesperance I., Aldridge H. E., Kazim F., Savatore E. A., Henderson M., Bonem E., Kabid P. R. Aspirin and dipyridamole in prevention of restonosis after percutaneous transluminal angioplasty. N. Engl. J. Med. 1988; 318: 1714–1719
   PubMed Web of Science ®Google Scholar
• Thornton M. A., Gruentzig A. R., Hollman J., King S. B., III, Douglas J. S. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty. 1984. Circulation 1984; 69: 721–727
   PubMed Web of Science ®Google Scholar
• Brockman M. J., Eiroa A. M., Marcus A. J. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothe-lial cells in suspension. Blockade of aggregation and secretion by aspirin-insensitive mechanism. Blood 1991; 78: 1033–1040
   Google Scholar
• Marcus A. J., Safier L. B., Hajjar K. A., Ullman H. L., Islam N., Brookman M. J., Eiroa A. M. Inhibition of platelet activation by aspirin-insensitive endothelial cell ADPase: thromboregulation of endothelial cells. J. Clin. Invest. 1991; 88: 1690–1696.
   PubMed Web of Science ®Google Scholar
• Rao A. K. Congenital disorders of platelet function. Hematol. Oncol. Clin. North Am. 1990; 4: 65–86
   Google Scholar
• Weiss H. J. Inherited abnormalities of platelet granules and signal transduction. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, R. W. Colman, J. Hirsh, V. J. Marder, E. W. Saltzman. Lippincott, Philadelphia, PA 1994; 673–684
   Google Scholar
• Rinder C. S., Student L. A., Bonan J. L., Rinder H. M., Smith B. R. Aspirin does not inhibit adenosine diphosphate-induced platelet α-granule release. Blood 1993; 82: 505–512
   PubMed Web of Science ®Google Scholar
• Dillingham E. O., Lasslo A., Cater-Burks G., Bond S. E., Gollamundi R. Relationship between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor-4. Biochim. Biophys. Acta 1989; 990: 128–132
   Google Scholar
• Bell R. L., Kennerly D. A., Stanford N., Majerus P. W. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 3228–3241
   Google Scholar
• Billah M. M., Lapetina E. G., Cutarocasas P. Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets. J. Biol Chem. 1981; 256: 831–837
   Google Scholar
• Packham M. A., Livine A.-A., Ruben D. H., Rand M. L. Activation of phospholipase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, diacylglycerol kinase inhibitor R59022, staurosporine and okodaic acid. Biochem. J. 1993; 290: 849–856
   PubMed Web of Science ®Google Scholar
• Pulcinelli F. M., Ashby B., Gazzauiiga P. P., Daniel J. L. Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets. FEBS Lett. 1995; 364: 87–90
   PubMedGoogle Scholar
• Friesen L. L., Gerrard J. M. The effects of 1-oleoyl-2-acetylglycerol on platelet phosphorylation and platelet ultra-structure. Am. J. Pathol. 1985; 121: 79–87
   PubMed Web of Science ®Google Scholar
• Gerrard J. M., Israelis S. J., Friesen L. L. Protein phosphorylation and platelet secretion. Nouv. Fr. Haematol. 1983; 27: 267–273
   Google Scholar
• Kaibuchi K., Takai Y., Sawamura M., Hosijima M., Fujikara T., Nishizuka Y. Synergistic functions of protein phosphorylation and calcium mobilization in platelets. J. Biol. Chem. 1983; 258: 6701–6704
   PubMed Web of Science ®Google Scholar
• Takai Y., Kishimoto A., Kikkawa U., Nishizuka Y. Unsaturated diacylglycerol as a possible messenger for the calcium-activated, phospholipid dependent protein kinase system. Biochem. Biophys. Res. Commun. 1979; 91: 1218–1224
   PubMed Web of Science ®Google Scholar
• Kishimoto A., Takai Y., Mori T., Kikkawa U., Nishizuka Y. Activation of calcium and phospholipid dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J. Biol. Chem. 1980; 255: 2273–2276
   PubMed Web of Science ®Google Scholar
• Gerrard J. M., Beattie L. L., Park J., Israels S. J., McNicol A., Lint D., Cragoe E. J., Jr. A role of protein kinase C in membrane fusion necessary for platelet granule secretion. Blood 1989; 74: 2405–2413
   Google Scholar
• Gilman A. G. G-proteins: transducers of receptor generated signals. Ann. Rev. Biochem. 1987; 56: 615–649
   PubMed Web of Science ®Google Scholar
• Raymond J. R. Multiple mechanisms of receptor-G protein signalling specificity. Am. J. Physiol. 1995; 38: F141–F158
   Google Scholar
• Brass L. F., Hoxie J. A., Manning D. R. Signalling through G proteins and G protein-coupled receptors during platelet activation. Thromb. Haemost. 1993; 70: 217–223
   PubMed Web of Science ®Google Scholar
• Gachet C., Cazenave J.-P., Ohlman P., Gerhard H., Wieland T., Jacob K. H. ADP-receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes. Eur. J. Biochem. 1992; 207: 259–263
   PubMedGoogle Scholar
• Laugwitz K.-L., Spicher K., Scultz G., Offermanns S. Identification of receptor-activated G-proteins: selective immunoprecipitation of photolabeled G-protein α-subunit. Methods Enzymol. 1994; 237: 283–294
   PubMedGoogle Scholar
• Ohlman P., Laugwitz K.-L., Nurnberg B., Spicher K., Scultz G., Cazenave J.-P., Gachet C. The human platelet ADP-receptor activates Gi2 proteins. Biochem. J. 1995; 312: 775–779
   Google Scholar
• Gachet C., Cazenave J.-P., Ohlmann P., Bouloux C., Defrreyn G., Driot F., Maffrand J.-P. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylyl cyclase of human platelets by PGE. Biochem. Pharmacol. 1990; 40: 2683–2687.
   PubMed Web of Science ®Google Scholar
• Clapham D. E., Neer E. J. New roles for G-protein βy-dimers in transmembrane signalling. Nature 1993; 365: 403–406
   PubMed Web of Science ®Google Scholar
• Léon C., Vial C., Cazenave J.-P., Gachet C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoreceptor. Gene 1996; 171: 295–297
   PubMed Web of Science ®Google Scholar
• Léon C., Hechler B., Vial C., Leray C., Cazenave J.-P., Gachet C. The P2Y, receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett. 1997; 403: 26–30
   PubMed Web of Science ®Google Scholar
• Mills D. C. B. ADP Receptors on platelets. Thromb. Haemost. 1996; 76: 835–56
   PubMed Web of Science ®Google Scholar
• Janssens R., Communi D., Pirotton S., Samson M., Parmentier M., Boeynames J.-M. Cloning and tissue distribution of the human P2Y1 receptor. Biochem. Biophys. Res. Commun. 1996; 221: 588–591
   PubMedGoogle Scholar
• Schacter J. B., Li Q., Boyer J. L., Nicholas R. A., Harden T. K. Second messenger cascade specificity and pharmacologiacl selectivity of the human P2Y1-purinoreceptor. Br. J. Pharmacol. 1996; 118: 167–173
   Google Scholar
• Defreyn G., Bemat A., Delebasse D., Maffrand J.-P. Pharmacology of toiclopidine: a review. Semin. Thromb. Hemost. 1989; 15: 159–166
   PubMed Web of Science ®Google Scholar
• Saltiel E., Ward A. Ticlopidine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficay in platelet-dependent disease states. Drugs 1987; 34: 22–262
   Google Scholar
• McTavish D., Faulds D., Gao K. L. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990; 40: 238–259
   PubMedGoogle Scholar
• Bruno J. J. The mechanism of action of ticlopidine. Thromb. Res. 1983; 59–67, Suppl IV
   Google Scholar
• Maffrand J.-P., Defreyn G., Bernat A., Delebasee D., Tissmier. Reviewed pharmacology of ticlopidine. Angiolgie 1988; 7: 6–13
   Google Scholar
• Herbert J. M., Frechel D., Vallee E., Kiefer G., Gouy D., Berger Y., Defreyn G., Maffrand J.-P. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc. Drug Rev. 1993; 11: 180–198
   Web of Science ®Google Scholar
• Savi P., Combalbert J., Gaich C., Rouchon M.-C., Maffrand J.-P., Berger Y. The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450–1A. Thromb. Haemost. 1994; 72: 313–317
   PubMed Web of Science ®Google Scholar
• Cattaneo M., Lombardi R., Bettega D., Leechi A., Mannuchi M. Shearinduced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. Arterioscl. Thromb. 1993; 13: 393–397
   PubMedGoogle Scholar
• Herbert J.-M., Bernat A., Maffrand J.-P. Aprotonin reduces clopidogrelinduced prolongation bleeding time in rats. Throm. Res. 1993; 71: 433–441
   PubMed Web of Science ®Google Scholar
• Nagakawa Y., Akedo Y., Orimo H., Yano H. Effect of combination of antiplatelet agents in man. Combination of aspirin, trapidil, ticlopidine and dipyridamole. Thromb. Res. 1990; 60: 469–475
   Google Scholar
• Savi P., Bemat A., Dumas A., Ait-Chek L., Herbert J.-M. Effects of aspirin and clopidogrel on platelet dependent tissue factor expression in endothelial cells. Thromb. Res. 1994; 73: 117–124
   PubMed Web of Science ®Google Scholar
• Steiger H., Hess H., Mietaschek A., Trampish H.-J., Ingrish H. Einfluss von ticlopidine auf die periphere obliterierendie Arteriopathie. Dtsch. Med. Wschr. 1984; 109: 1240–1249
   Google Scholar
• Levy R. I., Brensike J. F., Epstein S. E., Kelsey S. F., Passamanti E. R., Richardsson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W., Moriarty D. J., Fisher M. L., Friedman L., Friedwald W., Detere K. M. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease—Results of NHIBI Type JJ coronary intervention study. Circulation 1984; 69: 325–337
   PubMed Web of Science ®Google Scholar
• Berglund U., Wallentin L. Influence on lipoprotein metabolism of platelet inhibitory drug ticlopidine. Atherosclerosis 1986; 59: 241–246
   Google Scholar
• Humphries R. G., Tomlinson W., Clegg J. A., Ingall A. H., Kindon N. D., Leff P. Pharmacological profile of the novel P2T-purinoreceptor antagonist, FPL 67085 in vitro and in anesthesized rats in vivo. Br. J. Pharmacol. 1995; 115: 1110–1116
   PubMedGoogle Scholar
• Humphries R. G., Robertson M. J., Leff P. A novel series of P2T purinoreceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol. Sci. 1995; 16: 179–181
   PubMed Web of Science ®Google Scholar
• Humphries R. G., Tomlinson W., Ingall A. H., Cage P. A., Leff P. FPL 66096: a novel, highly potent and selective antagonist at human P2T purinoreceptor. Br. J. Pharmacol. 1994; 113: 1057–63
   PubMed Web of Science ®Google Scholar
• Chao F., Zamecnick P. C. Inhibition of platelet aggregation by Ap4A Hoppe Seyler′s Z. Physiol. Chem. 1984; 365: 610–611
   Google Scholar
• Louie S., Kim B. K., Zamecnik P. C. Diadenosine 5′,5′-P1,P4-tetraphosphate, a potential antithrombotic agent. Thromb. Res. 1988; 49: 557–566.
   Google Scholar
• Proctor R. A., Denlinger L. C., Leventhal P. S., Daugherty S. K., Van De Loo J.-W., Tanke T., Firestein G. S., Bertics P. J. Protection of mice from endotoxic death by 2-methylthio-ATP. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 6017–6020
   PubMed Web of Science ®Google Scholar
• Seiss W. Molecular mechanisms of platelet activation. Physiol. Rev. 1989; 69: 58–178
   Google Scholar
• Gachet C., Cazenave J.-P. ADP-induced blood platelet activation: a review. Nouv. Rev. Franc. Hematol. 1991; 33: 347–358
   PubMedGoogle Scholar
• Hourani S. M. O., Hall D. A. Receptors for ADP on human blood platelets. Trends Pharmacol. Sci. 1994; 15: 103–108
   PubMed Web of Science ®Google Scholar
• Mac Kenzie A. B., Mahaut-Smith M. P., Sage S. O. Activation of receptor-operated cation channel via P2X1 not P2T purinoreceptors in human platelets. J. Biol. Chem. 1996; 271: 2879–2881
   Google Scholar
• McFarlane D. E. Platelet responses and metabolism, H. Holmsen. CRC Press, Boca Raton, FL 1987; 19–36
   Google Scholar